These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 25460827
1. Prostaglandin E2 switches from a stimulator to an inhibitor of cell migration after epithelial-to-mesenchymal transition. Li YJ, Kanaji N, Wang XQ, Sato T, Nakanishi M, Kim M, Michalski J, Nelson AJ, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI. Prostaglandins Other Lipid Mediat; 2015; 116-117():1-9. PubMed ID: 25460827 [Abstract] [Full Text] [Related]
2. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors. Li YJ, Wang XQ, Sato T, Kanaji N, Nakanishi M, Kim M, Michalski J, Nelson AJ, Sun JH, Farid M, Basma H, Patil A, Toews ML, Liu X, Rennard SI. Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295 [Abstract] [Full Text] [Related]
3. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation. Iwanaga K, Okada M, Murata T, Hori M, Ozaki H. J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372 [Abstract] [Full Text] [Related]
4. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes. Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y. Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043 [Abstract] [Full Text] [Related]
5. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts. Shin JM, Park IH, Moon YM, Hong SM, Cho JS, Um JY, Lee HM. Am J Rhinol Allergy; 2014 Mar; 28(3):e120-4. PubMed ID: 24980222 [Abstract] [Full Text] [Related]
6. Prostaglandin E2 inhibits migration of colonic lamina propria fibroblasts. Rieder F, Georgieva M, Schirbel A, Artinger M, Zügner A, Blank M, Brenmoehl J, Schölmerich J, Rogler G. Inflamm Bowel Dis; 2010 Sep; 16(9):1505-13. PubMed ID: 20803697 [Abstract] [Full Text] [Related]
7. Involvement of endogenous prostaglandin E2 in tubular epithelial regeneration through inhibition of apoptosis and epithelial-mesenchymal transition in cisplatin-induced rat renal lesions. Yamamoto E, Izawa T, Juniantito V, Kuwamura M, Sugiura K, Takeuchi T, Yamate J. Histol Histopathol; 2010 Aug; 25(8):995-1007. PubMed ID: 20552550 [Abstract] [Full Text] [Related]
8. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells. Ueta M, Matsuoka T, Sotozono C, Kinoshita S. Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642 [Abstract] [Full Text] [Related]
9. The prostaglandin EP4 receptor is a master regulator of the expression of PGE2 receptors following inflammatory activation in human monocytic cells. Kashmiry A, Tate R, Rotondo G, Davidson J, Rotondo D. Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598 [Abstract] [Full Text] [Related]
10. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT. Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281 [Abstract] [Full Text] [Related]
11. PGE2 -induced migration of human brain endothelial cell is mediated though protein kinase A in cooperation of EP receptors. Khan GA, Bhagat S, Alam MI. J Leukoc Biol; 2019 Apr; 105(4):705-717. PubMed ID: 30835912 [Abstract] [Full Text] [Related]
12. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases. Lee J, Banu SK, Subbarao T, Starzinski-Powitz A, Arosh JA. Mol Cell Endocrinol; 2011 Jan 30; 332(1-2):306-13. PubMed ID: 21111772 [Abstract] [Full Text] [Related]
13. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones. Matsumoto S, Ikeda M, Yoshida S, Tanimoto T, Takeda M, Nasu M. Br J Pharmacol; 2005 Jun 30; 145(4):503-13. PubMed ID: 15821755 [Abstract] [Full Text] [Related]
14. Upregulation of the S1P3 receptor in metastatic breast cancer cells increases migration and invasion by induction of PGE2 and EP2/EP4 activation. Filipenko I, Schwalm S, Reali L, Pfeilschifter J, Fabbro D, Huwiler A, Zangemeister-Wittke U. Biochim Biophys Acta; 2016 Nov 30; 1861(11):1840-1851. PubMed ID: 27616330 [Abstract] [Full Text] [Related]
15. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells. Hsu HH, Lin YM, Shen CY, Shibu MA, Li SY, Chang SH, Lin CC, Chen RJ, Viswanadha VP, Shih HN, Huang CY. Int J Mol Sci; 2017 May 25; 18(6):. PubMed ID: 28587064 [Abstract] [Full Text] [Related]
16. Role of PGE2 in colonic motility: PGE2 attenuates spontaneous contractions of circular smooth muscle via EP4 receptors in the rat colon. Karaki SI, Tanaka R. J Physiol Sci; 2021 Feb 23; 71(1):8. PubMed ID: 33622238 [Abstract] [Full Text] [Related]
17. Prostaglandin E2 promotes human CD34+ cells homing through EP2 and EP4 in vitro. Wang Y, Lai S, Tang J, Feng C, Liu F, Su C, Zou W, Chen H, Xu D. Mol Med Rep; 2017 Jul 23; 16(1):639-646. PubMed ID: 28560401 [Abstract] [Full Text] [Related]
18. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation. Meja KK, Barnes PJ, Giembycz MA. Br J Pharmacol; 1997 Sep 23; 122(1):149-57. PubMed ID: 9298541 [Abstract] [Full Text] [Related]
19. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells. Elberg D, Turman MA, Pullen N, Elberg G. Prostaglandins Other Lipid Mediat; 2012 May 23; 98(1-2):11-6. PubMed ID: 22503965 [Abstract] [Full Text] [Related]
20. Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition. Singh T, Katiyar SK. PLoS One; 2011 May 23; 6(10):e25224. PubMed ID: 22022384 [Abstract] [Full Text] [Related] Page: [Next] [New Search]